Ä¢¹½ÊÓƵAPP

Katharine von Herrmann joined Ä¢¹½ÊÓƵAPP after completing the Ä¢¹½ÊÓƵAPP Fellowship. At Flagship, Katharine works as part of a team of entrepreneurial scientists to explore new areas of biology and develop the science, intellectual property, and business strategy that form the foundation of Flagship’s life science ventures. Katharine is focused on origination supporting Flagship’s Preemptive Health and Medicine initiative.

Before joining Flagship, Katharine earned her Ph.D. in Experimental and Molecular Medicine at Dartmouth. Her research focused on delineating the cellular and molecular mechanisms that underly the progression of Parkinson’s disease, and in doing so investigated the role of the NLRP3 inflammasome in neuroinflammation. Katharine received an NIH Ruth L. Kirschstein Predoctoral NRSA Fellowship to support this work. While at Dartmouth, Katharine served as President of the Graduate Student Council, mentored undergraduate students, and coached K-12 alpine ski racers at the local mountain. Katharine was also a Healthcare Fellow for Borealis Ventures.

Prior to her graduate studies, Katharine worked at the Spinal Muscular Atrophy Foundation, where she supported preclinical and clinical development of therapeutics for SMA.

Katharine holds a Ph.D. in Experimental and Molecular Medicine from the Guarini School of Graduate and Advanced Studies at Dartmouth. She received an M.S. in Biological Sciences and a B.A. in Biochemistry from Smith College.